Literature DB >> 10626674

Cytokines in genetic susceptibility to multiple sclerosis: a candidate gene approach. French Multiple Sclerosis Genetics Group.

J Reboul1, C Mertens, F Levillayer, S Eichenbaum-Voline, T Vilkoren, I Cournu, M C Babron, O Lyon-Caen, F Clerget-Darpoux, G Edan, M Clanet, M Brahic, J F Bureau, B Fontaine, R Liblau.   

Abstract

The immune system is involved in the pathophysiology of multiple sclerosis (MS) but the initiating antigen(s) is not yet identified. Since cytokines control both the intensity and the quality of the immune response they may be relevant candidates for the genetic susceptibility to MS. To analyze the contribution of type 1 and type 2 cytokine and cytokine receptor genes in the genetic susceptibility to MS, we have examined, in 116 French MS sibpairs, whether there is significant linkage between MS and 15 cytokine or cytokine receptor genes using 31 highly polymorphic genetic markers. The data were analyzed using the maximum likelihood score and the transmission disequilibrium approaches. None of the candidate genes tested was significantly linked to MS on the whole population. However, after stratification of the analysis on the basis of sharing (or not) of the HLA-DRB1*1501 allele, indication of linkage was found for the IL2-RB gene. These findings suggest that the IL2-RB locus contributes to the genetic susceptibility in a subgroup of MS patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10626674     DOI: 10.1016/s0165-5728(99)00158-7

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  8 in total

Review 1.  Genetic analysis of multiple sclerosis.

Authors:  Alastair Compston; Stephen Sawcer
Journal:  Curr Neurol Neurosci Rep       Date:  2002-05       Impact factor: 5.081

2.  Complex gene-gene interactions in multiple sclerosis: a multifactorial approach reveals associations with inflammatory genes.

Authors:  Alison A Motsinger; David Brassat; Stacy J Caillier; Henry A Erlich; Karen Walker; Lori L Steiner; Lisa F Barcellos; Margaret A Pericak-Vance; Silke Schmidt; Simon Gregory; Stephen L Hauser; Jonathan L Haines; Jorge R Oksenberg; Marylyn D Ritchie
Journal:  Neurogenetics       Date:  2006-09-22       Impact factor: 2.660

Review 3.  Insights into the immunopathogenesis of multiple sclerosis.

Authors:  Niels Hellings; Jef Raus; Piet Stinissen
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

Review 4.  Modulation of IL-2Rα with daclizumab for treatment of multiple sclerosis.

Authors:  Heinz Wiendl; Catharina C Gross
Journal:  Nat Rev Neurol       Date:  2013-06-04       Impact factor: 42.937

Review 5.  Association between Tumor Necrosis Factor- α-308 G/A Polymorphism and Multiple Sclerosis: A Systematic Review and Meta-Analysis.

Authors:  Hamidreza Tolide-Ie; Hamid Reza Tabatabaee; Eskandar Kamali-Sarvestani
Journal:  Iran J Med Sci       Date:  2014-01

6.  The association of -330 interleukin-2 gene polymorphism with its plasma concentration in Iranian multiple sclerosis patients.

Authors:  Arezou Sayad; Abolfazl Movafagh
Journal:  Scientifica (Cairo)       Date:  2014-05-19

Review 7.  Environmental Influencers, MicroRNA, and Multiple Sclerosis.

Authors:  Eiman Ma Mohammed
Journal:  J Cent Nerv Syst Dis       Date:  2020-01-20

8.  The association of -475 and -631 interleukin-2 gene polymorphism with multiple sclerosis in Iranian patients.

Authors:  Aida Sayad; Abdolamir Allameh; Arezou Sayad; Mehrdad Noruzinia; Mohammad Taghi Akbari; Ali Sarzaeem; Akbari Akbar; Reza Haji Hoseini
Journal:  Cell J       Date:  2013-07-02       Impact factor: 2.479

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.